Lipid lowering in liver and chronic kidney disease

Keyphrases

• Liver 100%
• Chronic Kidney Disease 100%
• Lipid-lowering 100%
• Cardiovascular Risk 60%
• Liver Disease 40%
• Chronic Liver Disease 40%
• Statins 40%
• Lipid Compounds 40%
• Lipid Metabolism 20%
• Lipids 20%
• Renal Transplant Recipients 20%
• Outcome Trials 20%
• Creatinine Clearance 20%
• Kidney Disease 20%
• Cardiovascular Outcomes 20%
• Present Challenges 20%
• Lipid-lowering Medications 20%
• HMG-CoA Reductase Inhibitors 20%
• Nonstatin Therapy 20%
• Dyslipidemia Management 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Chronic Kidney Failure 100%
• Liver Disease 40%
• Chronic Liver Disease 40%
• Cardiovascular Risk 40%
• Statin (Protein) 40%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 40%
• Dyslipidemia 20%
• Creatinine 20%
• Kidney Disease 20%
• Cardiovascular Disease 20%

Medicine and Dentistry

• Liver Disease 60%